142 related articles for article (PubMed ID: 7062507)
1. Urine free-cortisol determination. A useful tool in the management of chronic hypoadrenal states.
Burch WM
JAMA; 1982 Apr; 247(14):2002-4. PubMed ID: 7062507
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism.
Barbetta L; Dall'Asta C; Re T; Libè R; Costa E; Ambrosi B
J Endocrinol Invest; 2005; 28(7):632-7. PubMed ID: 16218046
[TBL] [Abstract][Full Text] [Related]
3. Dose distribution in hydrocortisone replacement therapy has a significant influence on urine free cortisol excretion.
Bliesener N; Steckelbroeck S; Redel L; Klingmüller D
Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):443-6. PubMed ID: 14614652
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey SR; Guo CY; Robinson AM; Price A; Giles MA; Eastell R; Weetman AP
Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.
Alonso N; Granada ML; Lucas A; Salinas I; Reverter J; Oriol A; Sanmarti A
J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of adrenal cortex insufficiency].
Diederich S; Bähr V; Oelkers W
Dtsch Med Wochenschr; 1994 Apr; 119(16):595-7. PubMed ID: 8162843
[No Abstract] [Full Text] [Related]
7. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements.
Arlt W; Rosenthal C; Hahner S; Allolio B
Clin Endocrinol (Oxf); 2006 Apr; 64(4):384-9. PubMed ID: 16584509
[TBL] [Abstract][Full Text] [Related]
8. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
Løvås K; Thorsen TE; Husebye ES
J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
[TBL] [Abstract][Full Text] [Related]
9. Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients.
Wong V; Yan T; Donald A; McLean M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):131-7. PubMed ID: 15212655
[TBL] [Abstract][Full Text] [Related]
10. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
[TBL] [Abstract][Full Text] [Related]
11. The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.
Dineen R; Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Keevil BG; Tormey W; Smith D; Thompson CJ; McKenna MJ; Arlt W; Stewart PM; Agha A; Sherlock M
BMC Endocr Disord; 2020 Oct; 20(1):154. PubMed ID: 33036588
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
[TBL] [Abstract][Full Text] [Related]
13. [The excretion of free cortisol in the urine in healthy children and in asthmatics treated with long-term inhaled glucocorticoids].
Gónzález Pérez-Yarza E; Mintegui J; Garmendia A; Callén M; Reguilón MJ; Garrido A; Emparanza JI
An Esp Pediatr; 1996 Jun; 44(6):531-6. PubMed ID: 8796962
[TBL] [Abstract][Full Text] [Related]
14. Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses.
Laureti S; Falorni A; Santeusanio F
J Endocrinol Invest; 2003 Nov; 26(11):1071-5. PubMed ID: 15008243
[TBL] [Abstract][Full Text] [Related]
15. Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy.
Dineen R; Stewart PM; Sherlock M
Clin Endocrinol (Oxf); 2019 Jan; 90(1):3-14. PubMed ID: 30120786
[TBL] [Abstract][Full Text] [Related]
16. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles.
Ekman B; Blomgren J; Andersson PO; Carlsson M; Arnqvist HJ
Horm Metab Res; 2010 Dec; 42(13):961-6. PubMed ID: 20925018
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of adrenal cortex insufficiency].
Quinkler M; Lepenies J; Diederich S
Dtsch Med Wochenschr; 2003 Mar; 128(12):617-8. PubMed ID: 12649799
[No Abstract] [Full Text] [Related]
18. Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism.
Watanabe T; Ozawa A; Ishii S; Tomaru T; Shibusawa N; Saito T; Yamada E; Horiguchi K; Nakajima Y; Matsumoto S; Yoshino S; Katano-Toki A; Hashimoto K; Mori M; Okada S; Satoh T; Yamada M
Endocr J; 2018 May; 65(5):547-556. PubMed ID: 29618670
[TBL] [Abstract][Full Text] [Related]
19. GDF15 Is Elevated in Conditions of Glucocorticoid Deficiency and Is Modulated by Glucocorticoid Replacement.
Melvin A; Chantzichristos D; Kyle CJ; Mackenzie SD; Walker BR; Johannsson G; Stimson RH; O'Rahilly S
J Clin Endocrinol Metab; 2020 May; 105(5):1427-34. PubMed ID: 31853550
[TBL] [Abstract][Full Text] [Related]
20. Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution.
Blomgren J; Ekman B; Andersson PO; Arnqvist HJ
Scand J Clin Lab Invest; 2004 Apr; 64(2):132-9. PubMed ID: 15115251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
